Myeloid cell-targeted therapies for solid tumours

S Goswami, S Anandhan, D Raychaudhuri… - Nature Reviews …, 2023 - nature.com
Myeloid cells are the most abundant immune components of the tumour microenvironment,
where they have a variety of functions, ranging from immunosuppressive to …

[HTML][HTML] Key chemokines direct migration of immune cells in solid tumors

K Kohli, VG Pillarisetty, TS Kim - Cancer gene therapy, 2022 - nature.com
Immune cell infiltration into solid tumors, their movement within the tumor microenvironment
(TME), and interaction with other immune cells are controlled by their directed migration …

[HTML][HTML] Regulatory cells and the effect of cancer immunotherapy

M Iglesias-Escudero, N Arias-González… - Molecular Cancer, 2023 - Springer
Several mechanisms and cell types are involved in the regulation of the immune response.
These include mostly regulatory T cells (Tregs), regulatory macrophages (Mregs), myeloid …

Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment

L Li, R Yu, T Cai, Z Chen, M Lan, T Zou, B Wang… - International …, 2020 - Elsevier
Chronic inflammation and immune responses are two core element that characterize the
tumor microenvironment. A large number of immune/inflammatory cells (including tumor …

[HTML][HTML] The effect of hypoxia on the expression of CXC chemokines and CXC chemokine receptors—a review of literature

J Korbecki, K Kojder, P Kapczuk, P Kupnicka… - International Journal of …, 2021 - mdpi.com
Hypoxia is an integral component of the tumor microenvironment. Either as chronic or
cycling hypoxia, it exerts a similar effect on cancer processes by activating hypoxia-inducible …

[HTML][HTML] Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ

Y Liu, Y Deguchi, D Wei, F Liu, MJ Moussalli… - Nature …, 2022 - nature.com
Pancreatic intraepithelial neoplasia (PanIN) is a precursor of pancreatic ductal
adenocarcinoma (PDAC), which commonly occurs in the general populations with aging …

Targeting MDSC for immune-checkpoint blockade in cancer immunotherapy: current progress and new prospects

T Li, T Liu, W Zhu, S Xie, Z Zhao… - Clinical Medicine …, 2021 - journals.sagepub.com
Immune-checkpoint blockade (ICB) demonstrated inspiring effect and great promise in anti-
cancer therapy. However, many obstacles, such as drug resistance and difficulty in patient …

Therapeutic developments in pancreatic cancer

ZI Hu, EM O'Reilly - Nature Reviews Gastroenterology & Hepatology, 2023 - nature.com
Pancreatic ductal adenocarcinoma (PDAC) has a rising incidence and is one of the most
lethal human malignancies. Much is known regarding the biology and pathophysiology of …

[HTML][HTML] IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma

R Weber, Z Riester, L Hüser, C Sticht… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Myeloid-derived suppressor cells (MDSC) play a major role in the
immunosuppressive melanoma microenvironment. They are generated under chronic …

[HTML][HTML] Immunometabolic reprogramming, another cancer hallmark

V Kumar, JH Stewart IV - Frontiers in Immunology, 2023 - frontiersin.org
Molecular carcinogenesis is a multistep process that involves acquired abnormalities in key
biological processes. The complexity of cancer pathogenesis is best illustrated in the six …